Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ultralife (ULBI) EPS (Weighted Average and Diluted) (2016 - 2025)

Ultralife has reported EPS (Weighted Average and Diluted) over the past 16 years, most recently at -$35.09 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$35.09 for Q4 2025, down 193.25% from a year ago — trailing twelve months through Dec 2025 was -$35.09 (down 192.56% YoY), and the annual figure for FY2025 was -$35.0, down 192.11%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$35.09 at Ultralife, down from -$0.07 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for ULBI hit a ceiling of $37.63 in Q4 2024 and a floor of -$35.09 in Q4 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.03 (2022), compared with a mean of $0.38.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 22035.29% in 2024 and later tumbled 450.0% in 2025.
  • Ultralife's EPS (Weighted Average and Diluted) stood at -$0.1 in 2021, then soared by 130.0% to $0.03 in 2022, then surged by 466.67% to $0.17 in 2023, then skyrocketed by 22035.29% to $37.63 in 2024, then plummeted by 193.25% to -$35.09 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$35.09 (Q4 2025), -$0.07 (Q3 2025), and $0.05 (Q2 2025) per Business Quant data.